The Urgency of Patient Recruitment in Infectious Disease & Immunology
Infectious disease and immunology studies often operate under intense pressure. From pandemic preparedness to vaccine development and immune therapy trials, every day matters.
- Rapid timelines requiring immediate patient engagement.
- Patient fear or stigma associated with infectious conditions.
- Diversity gaps, especially in pediatric and minority populations.
- Logistical barriers for at-risk or immunocompromised patients.
Delays in enrollment risk undermining public health initiatives and slowing the delivery of critical therapies.
Trusted, rapid, and compliance-first patient recruitment for infectious disease and immunology trials, powered by OMNI CRS’ performance marketing engine.
OMNI CRS is more than a patient recruitment vendor. We are a strategic partner that ensures infectious disease trials meet their enrollment goals with speed, compliance, and patient diversity.
Patient Recruitment Expertise That Delivers Results
122,901 leads generated
14.8% of OMNI CRS portfolio
Vaccine study dominance
86,647 leads across 35+ campaigns
COVID-19 specialization
10,095 leads across 12 studies
Pediatric vaccine expertise
7,275 leads delivered
How We Deliver Reliable Enrollment
Our recruitment strategies combine urgency with compliance, ensuring high-quality referrals for sponsors, CROs, and sites:
- Performance-driven outreach: Email, search, social campaigns, and native placements
- Data-led targeting: Advanced analytics to segment by demographics, health history, and risk profile
- Diversity-first acquisition Inclusive campaigns and partnerships with community organizations
- Compliance-first execution HIPAA, GDPR, FDA, and IRB-approved messaging built into every program
Results That Rapidly Advance Pain Clinical Trial Enrollment
OMNI CRS has delivered faster enrollment and higher retention in vaccine and infectious disease studies—helping sponsors and CROs stay ahead of urgent timelines.
For example, across vaccine campaigns, OMNI CRS provided 86k+ participants while reducing screen failures through compliance-first validation. In COVID-19 studies, our tailored outreach cut enrollment timeframes by weeks, ensuring studies launched on schedule.
Partner With OMNI CRS to Accelerate Your Infectious Disease Enrollment
Your trial deserves a recruitment partner who understands the stakes. OMNI CRS delivers scale through its national reach, precision through data-driven targeting, and confidence through compliance-first execution.